Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Wheeler

Showing results (861-870 of 1,217) with videos related to

Pageof 122
Sort By:
Clinical Journal of the American Society of Nephrology : CJASN|April 24, 2021
Understanding and Overcoming the Challenges Related to Cardiovascular Trials Involving Patients with Kidney DiseaseJulie H Ishida, Cynthia Chauhan, Barbara Gillespie, et al.
BMJ Open|July 16, 2025
Patient-reported outcome measures for fatigue in patients with chronic kidney disease: a systematic reviewAnastasia Hughes, Angela Ju, Rosanna Cazzolli, et al.
Clinical Kidney Journal|February 5, 2024
Potentially modifiable factors associated with health-related quality of life among people with chronic kidney disease: baseline findings from the National Unified Renal Translational Research Enterprise CKD (NURTuRE-CKD) cohortThomas Phillips, Scott Harris, Olalekan Lee Aiyegbusi, et al.
Scientific Reports|December 27, 2023
Cannabis Sativa targets mediobasal hypothalamic neurons to stimulate appetiteEmma C Wheeler, Pique Choi, Joanne De Howitt, et al.
Journal of Huntington'S Disease|October 8, 2015
The Genetic Modifiers of Motor OnsetAge (GeM MOA) Website: Genome-wide Association Analysis for Genetic Modifiers of Huntington's DiseaseKevin Correia, Denise Harold, Kyung-Hee Kim, et al.
Plos One|September 13, 2012
Msh2 acts in medium-spiny striatal neurons as an enhancer of CAG instability and mutant huntingtin phenotypes in Huntington's disease knock-in miceMarina Kovalenko, Ella Dragileva, Jason St Claire, et al.
Glomerular Diseases|August 15, 2024
Effects of Dapagliflozin in Patients with Membranous NephropathyGlenn M Chertow, Hiddo Lambers Heerspink, Patrick B Mark, et al.
Journal of Intellectual Disability Research : JIDR|September 2, 2025
Parental Stress and Family Quality of Life in Families of Individuals Living With Angelman SyndromeCatherine Merton, Angela Gwaltney, Anna Booman, et al.
Genetics|August 22, 2003
Identification of quantitative trait loci influencing wood property traits in loblolly pine (Pinus taeda L.). III. QTL Verification and candidate gene mappingGarth R Brown, Daniel L Bassoni, Geoffrey P Gill, et al.
Human Molecular Genetics|January 15, 1999
Length-dependent gametic CAG repeat instability in the Huntington's disease knock-in mouseV C Wheeler, W Auerbach, J K White, et al.
Pageof 122

Showing results (861-870 of 1,217) with videos related to

Sort By:
Pageof 122
Clinical Journal of the American Society of Nephrology : CJASN|April 24, 2021
Understanding and Overcoming the Challenges Related to Cardiovascular Trials Involving Patients with Kidney DiseaseJulie H Ishida, Cynthia Chauhan, Barbara Gillespie, et al.
BMJ Open|July 16, 2025
Patient-reported outcome measures for fatigue in patients with chronic kidney disease: a systematic reviewAnastasia Hughes, Angela Ju, Rosanna Cazzolli, et al.
Clinical Kidney Journal|February 5, 2024
Potentially modifiable factors associated with health-related quality of life among people with chronic kidney disease: baseline findings from the National Unified Renal Translational Research Enterprise CKD (NURTuRE-CKD) cohortThomas Phillips, Scott Harris, Olalekan Lee Aiyegbusi, et al.
Scientific Reports|December 27, 2023
Cannabis Sativa targets mediobasal hypothalamic neurons to stimulate appetiteEmma C Wheeler, Pique Choi, Joanne De Howitt, et al.
Journal of Huntington'S Disease|October 8, 2015
The Genetic Modifiers of Motor OnsetAge (GeM MOA) Website: Genome-wide Association Analysis for Genetic Modifiers of Huntington's DiseaseKevin Correia, Denise Harold, Kyung-Hee Kim, et al.
Plos One|September 13, 2012
Msh2 acts in medium-spiny striatal neurons as an enhancer of CAG instability and mutant huntingtin phenotypes in Huntington's disease knock-in miceMarina Kovalenko, Ella Dragileva, Jason St Claire, et al.
Glomerular Diseases|August 15, 2024
Effects of Dapagliflozin in Patients with Membranous NephropathyGlenn M Chertow, Hiddo Lambers Heerspink, Patrick B Mark, et al.
Journal of Intellectual Disability Research : JIDR|September 2, 2025
Parental Stress and Family Quality of Life in Families of Individuals Living With Angelman SyndromeCatherine Merton, Angela Gwaltney, Anna Booman, et al.
Genetics|August 22, 2003
Identification of quantitative trait loci influencing wood property traits in loblolly pine (Pinus taeda L.). III. QTL Verification and candidate gene mappingGarth R Brown, Daniel L Bassoni, Geoffrey P Gill, et al.
Human Molecular Genetics|January 15, 1999
Length-dependent gametic CAG repeat instability in the Huntington's disease knock-in mouseV C Wheeler, W Auerbach, J K White, et al.
Pageof 122